Global RT-PCR Test Kits Market Size, Share, and COVID-19 Impact Analysis, By Type (One-step Real Time PCR, Two-step Real Time PCR), By Application (Microbiology, Oncology, Gene Therapy, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare

RELEASE DATE Jul 2024
REPORT ID SI5275
PAGES 287
REPORT FORMAT PathSoft

Global RT-PCR Test Kits Market Insights Forecasts to 2033

  • The Global RT-PCR Test Kits Market Size was Valued at USD 3.98 Billion in 2023
  • The Market Size is Growing at a CAGR of 5.99% from 2023 to 2033
  • The Worldwide RT-PCR Test Kits Market Size is Expected to Reach USD 7.12 Billion by 2033
  • Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Global RT-PCR Test Kits Market

Get more details on this report -

Request Free Sample PDF

 

The RT-PCR Test Kits Market Size is Anticipated to Exceed USD 7.12 Billion by 2033, Growing at a CAGR of 5.99% from 2023 to 2033.

 

Market Overview

RT-PCR kits will be used strictly for detecting, identifying, and diagnosing infectious disorders, particularly pathogens. The COVID-19 pandemic is a prime example of the exponential rise in demand. Very simply stated, the pandemic was one of the riskiest humanitarian crises in recent times. More than 600 million people have been infected as of right now. As it happens, the death rate has dropped dramatically as a result of the readily available quick diagnostic kits, which enable prompt infection detection and appropriate treatment. Additionally, government testing facilities around the nation are receiving supplies of COVID-19 diagnostic RT-PCR kits that are imported from the United States. Two commercial businesses, MyLab, an Indian company, and Altona Diagnostics, a German company, have recently been granted permission by the government to provide RT-PCR kits to government and private testing facilities. The global rise in COVID-19 infections is a primary driver of the RT-PCR kits market expansion. There has been an exponential rise in the number of COVID-19 infections. Because lockdowns are becoming more commonplace worldwide, there will be a greater need for RT-PCR kits as the number of patients rises. Up until February 2022, 424,822,073 COVID-19 cases were confirmed, according to the WHO. More RT-PCR kits are needed as a result of the rise in COVID-19 cases, which is driving up market forecasts.

 

Report Coverage

This research report categorizes the market for the RT-PCR test kits market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the RT-PCR test kits market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the RT-PCR test kits market.

 

Global RT-PCR Test Kits Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 3.98 Billion
Forecast Period:2023 - 2033
Forecast Period CAGR 2023 - 2033 :5.99%
2033 Value Projection:USD 7.12 Billion
Historical Data for:2019 - 2022
No. of Pages:287
Tables, Charts & Figures:110
Segments covered:By Type, By Application, By Region
Companies covered:: Thermo Fisher, Hologic, LabCorp, Quidel Corporation, Abbott, Qiagen, Cellex, Roche, BioMedomics, BD, AB Analitica, HiMedia Laboratories, Altona Diagnostics GmbH, Ampliqon, Elisabeth, Fuj, Others, and
Pitfalls & Challenges:COVID-19 Empact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The RT-PCR kits have been used in a variety of applications, including fundamental and diagnostic research. Human genetic testing, forensic sciences, pathogen identification, cancer testing, blood screening, and infectious disease testing are a few of the main end-use applications. Furthermore, the kits have been increasingly being used in the food microbiology field to detect food adulteration, which is anticipated to drive market demand.

 

Restraining Factors

As the pandemic spreads over the world, there will probably be less demand for testing, which could lead the market for COVID-19 detection kits to diminish. A major factor in the anticipated market reduction is the declining number of new cases and overall demand for testing.

 

Market Segmentation

The RT-PCR test kits market share is classified into type and application.

  • The one-step real time PCR segment is expected to hold the largest share of the RT-PCR test kits market during the forecast period.   

Based on the type, the RT-PCR test kits market is categorized into one-step real time PCR, and two-step real time PCR. Among these, the one-step real time PCR segment is expected to hold the largest share of the RT-PCR test kits market during the forecast period. The one-step RT-PCR was designed for the easy, accurate, and repeatable RT-PCR detection and analysis of RNA molecules. Target RNAs from either total RNA or mRNA, along with gene-specific primers, are combined for both cDNA synthesis and PCR in a single tube. Without further procedures, reverse transcription happens automatically after PCR cycling.

 

  • The gene therapy segment is expected to grow at the fastest CAGR during the forecast period.   

Based on the application, the RT-PCR test kits market is categorized into microbiology, oncology, gene therapy, and others. Among these, the gene therapy segment is expected to grow at the fastest CAGR during the forecast period. The utilization is essential in the precise, dependable, and large-scale genome titration of viral vector preparations, particularly those that are constructed using AAV. This procedure is strictly regulated on several fronts, including the reaction itself and the surrounding lab procedures used to ensure a productive PCR run. Generic primer/probe sets have been created for the quantification of vectors carrying various promoters and genes of interest.

 

Regional Segment Analysis of the Global RT-PCR Test Kits Market

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is projected to hold the largest share of the RT-PCR test kits market over the forecast period.

 

Global RT-PCR Test Kits Market

Get more details on this report -

Request Free Sample PDF

 

North America is projected to hold the largest share of the RT-PCR test kits market over the forecast period. The existence of advanced, well-equipped healthcare institutions in the United States and Canada is the reason for the regional growth. Additionally, the market share will be increased by growing healthcare costs brought on by increased awareness. Furthermore, rising healthcare costs and the incidence of COVID-19 infections are predicted to improve the market outlook in the forecast period. The region's need for RT-PCR test kits was driven by the high rate of COVID-19 infections. As a result, to increase testing capacity and support the growth of the region, regulatory organizations including the U.S. FDA and Health Canada regularly give coronavirus test kits Emergency Use Authorizations (EUA).

 

Asia Pacific is expected to grow at the fastest CAGR growth of the RT-PCR test kits market during the forecast period. Japan, China, India, Australia, South Korea, and the remaining Asia Pacific nations are all part of the Asia Pacific market. The Asia Pacific region has witnessed a notable surge in healthcare spending due to various factors, including the middle-class population's increasing disposable income and the continuous economic growth of several Asia Pacific countries.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the RT-PCR test kits market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Thermo Fisher
  • Hologic
  • LabCorp
  • Quidel Corporation
  • Abbott
  • Qiagen
  • Cellex
  • Roche
  • BioMedomics
  • BD
  • AB Analitica
  • HiMedia Laboratories
  • Altona Diagnostics GmbH
  • Ampliqon
  • Elisabeth
  • Fuj
  • Others

 

Key Market Developments

  • In December 2023, HiMedia Laboratories has introduced its HiGenoMB RT-PCR kits, which are capable of detecting the SARS-CoV-2 JN.1 variation, which is a derivative of the Omicron BA.2.86 (Pirola) variety. Because of its ability to evade the immune system, the JN.1 variety has been designated as a variant of concern and is responsible for a rising number of cases globally.

 

  • In January 2022, Roche Diagnostics India has launched a new COVID-19 At-Home Test, an over-the-counter test designed to diagnose SARS-CoV-2 infection in people exhibiting COVID-19 symptoms. For those who think they could have contracted the coronavirus, this test makes it easy for them to check for the infection from the comfort of their own homes. It's a quick and convenient solution.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global RT-PCR test kits market based on the below-mentioned segments: 

 

Global RT-PCR Test Kits Market, By Type

  • One-step Real Time PCR
  • Two-step Real Time PCR

 

Global RT-PCR Test Kits Market, By Application

  • Microbiology
  • Oncology
  • Gene Therapy
  • Others

 

Global RT-PCR Test Kits Market, By Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions (FAQ)

  • 1.What is the CAGR of the global RT-PCR test kits market over the forecast period?
    The RT-PCR Test Kits Market Size is Expected to Grow from USD 3.98 Billion in 2023 to USD 7.12 Billion by 2033, at a CAGR of 5.99% during the forecast period 2023-2033.
  • 2.Which region is expected to hold the highest share in the RT-PCR test kits market?
    North America is projected to hold the largest share of the RT-PCR test kits market over the forecast period.
  • 3.Who are the top key players in the RT-PCR test kits market?
    Thermo Fisher, Hologic, LabCorp, Quidel Corporation, Abbott, Qiagen, Cellex, Roche, BioMedomics, BD, AB Analitica, Altona Diagnostics GmbH, Ampliqon, Elisabeth, Fuj, and others.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies